CD38 and neoplasm: Therefore, a rational approach for reducing on-target/off-tumor effects of anti-CD38 CAR-T cells using caspase-9-based suicide gene or affinity optimization has been developed and showed highly suitability for the generation of optimal CARs [79, 81].